Growth Regulation Section
$427,052ZIAFY2017CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications & trials
Paper 36968141Paper 33719575Paper 33137336Paper 31133737Paper 31019291Paper 30379099Paper 28709637Paper 28266632Paper 28100250Paper 27570066Paper 27196771Paper 27187580Paper 26894650Paper 26261303Paper 26072030Paper 25962108Paper 25803818Paper 25728039Paper 25673808Paper 25587125Paper 24633808Paper 22666460Paper 22402205Paper 22234308Paper 21842266Paper 21822313Paper 21669876Paper 19898744Paper 19669888Paper 19513534Paper 19495750Paper 19250639Paper 19128473Paper 17397028Paper 17308099Paper 16585525Paper 16537515Paper 16397215Paper 16364570Paper 15798027Paper 15326299Paper 15276201Paper 15150260Paper 14981236Paper 14652002Paper 12894516Paper 12865322Paper 12746837Paper 12670487Paper 12538848
Abstract
We are collaborating with Serguei Kozlov (Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, MD) and Christine Alewine (LMB) to determine if mesothelin is needed for pancreatic cancer development or progression. To do this KPC mice, which develop pancreatic cancers, have been crossed with mesothelin -/- mice. KPC mice not making mesothelin have been obtained and are being followed for development of pancreatic cancer. If cancer develops we will then determine how long the mice live and if the cancer spreads.
View original record on NIH RePORTER →